Embed this press release by copying the code below:

Amy M. Scott-Billman, Vice President of Global Regulatory Strategy for Immunotherapeutics at GlaxoSmithKline Biologicals, to Give Keynote Presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit on October 14-16, 2009 in San Diego, CA